GSK False Ad Suit Over Teva's Generic Wellbutrin Frozen
A Pennsylvania federal judge on Friday suspended a false advertising suit by GlaxoSmithKline LLC against Teva Pharmaceuticals USA Inc. over Teva's marketing of its generic Wellbutrin as equivalent to the brand-name...To view the full article, register now.
Already a subscriber? Click here to view full article